In a 12-week phase II pilot in 42 older adults with amnestic MCI who completed it, nicotinamide riboside doubled blood NAD+ but did not improve cognitive function (primary outcome), total cerebral blood flow or blood pressure vs placebo.
RCTn = 42
Martens et al. A phase-II randomized controlled pilot study of nicotinamide riboside supplementation in older adults with amnestic mild cognitive impairment